Home >> Pharmaceuticals >> Food & Beverage >>

Ascendis Pharma A/S - Product Pipeline Review - 2015

Published: Apr-2015 | Format: PDF | Global Markets Direct | Number of pages: 33 | Code: MRS - 18287

Ascendis Pharma A/S - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Ascendis Pharma A/S - Product Pipeline Review - 2015’, provides an overview of the Ascendis Pharma A/S’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ascendis Pharma A/S’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Ascendis Pharma A/S including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Ascendis Pharma A/S’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Ascendis Pharma A/S’s pipeline products

Reasons to buy

- Evaluate Ascendis Pharma A/S’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Ascendis Pharma A/S in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Ascendis Pharma A/S’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Ascendis Pharma A/S and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ascendis Pharma A/S
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Ascendis Pharma A/S and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Ascendis Pharma A/S Snapshot 5
Ascendis Pharma A/S Overview 5
Key Information 5
Key Facts 5
Ascendis Pharma A/S - Research and Development Overview 6
Key Therapeutic Areas 6
Ascendis Pharma A/S - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
Ascendis Pharma A/S - Pipeline Products Glance 14
Ascendis Pharma A/S - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Phase I Products/Combination Treatment Modalities 15
Ascendis Pharma A/S - Early Stage Pipeline Products 16
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
Ascendis Pharma A/S - Drug Profiles 18
ACP-001 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
treprostinil 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ACP-005 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
pramipexole dihydrochloride 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
ACP-007 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
ACP-008 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Ascendis Pharma A/S - Pipeline Analysis 25
Ascendis Pharma A/S - Pipeline Products by Target 25
Ascendis Pharma A/S - Pipeline Products by Route of Administration 26
Ascendis Pharma A/S - Pipeline Products by Molecule Type 27
Ascendis Pharma A/S - Pipeline Products by Mechanism of Action 28
Ascendis Pharma A/S - Recent Pipeline Updates 29
Ascendis Pharma A/S - Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 32
Disclaimer 33

List of Tables
Ascendis Pharma A/S, Key Information 5
Ascendis Pharma A/S, Key Facts 5
Ascendis Pharma A/S - Pipeline by Indication, 2015 7
Ascendis Pharma A/S - Pipeline by Stage of Development, 2015 8
Ascendis Pharma A/S - Monotherapy Products in Pipeline, 2015 9
Ascendis Pharma A/S - Partnered Products in Pipeline, 2015 10
Ascendis Pharma A/S - Partnered Products/ Combination Treatment Modalities, 2015 11
Ascendis Pharma A/S - Out-Licensed Products in Pipeline, 2015 12
Ascendis Pharma A/S - Out-Licensed Products/ Combination Treatment Modalities, 2015 13
Ascendis Pharma A/S - Phase II, 2015 14
Ascendis Pharma A/S - Phase I, 2015 15
Ascendis Pharma A/S - Preclinical, 2015 16
Ascendis Pharma A/S - Discovery, 2015 17
Ascendis Pharma A/S - Pipeline by Target, 2015 25
Ascendis Pharma A/S - Pipeline by Route of Administration, 2015 26
Ascendis Pharma A/S - Pipeline by Molecule Type, 2015 27
Ascendis Pharma A/S - Pipeline Products by Mechanism of Action, 2015 28
Ascendis Pharma A/S - Recent Pipeline Updates, 2015 29
Ascendis Pharma A/S, Subsidiaries 31

List of Figures
Ascendis Pharma A/S - Pipeline by Top 10 Indication, 2015 7
Ascendis Pharma A/S - Pipeline by Stage of Development, 2015 8
Ascendis Pharma A/S - Monotherapy Products in Pipeline, 2015 9
Ascendis Pharma A/S - Out-Licensed Products in Pipeline, 2015 12
Ascendis Pharma A/S - Pipeline by Top 10 Target, 2015 25
Ascendis Pharma A/S - Pipeline by Top 10 Route of Administration, 2015 26
Ascendis Pharma A/S - Pipeline by Top 10 Molecule Type, 2015 27
Ascendis Pharma A/S - Pipeline Products by Top 10 Mechanism of Action, 2015 28

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing